Since loss of NF1 can also be accomplished via mechanisms other than loss-of-function mutations, such as epigenetic gene silencing or aberrant protein stability [33, 67], analysis of NF1 protein levels in tumor biopsies may be of importance to correctly stratify the patient population for targeted therapy against the MAPK signaling pathway. Here, NF1 is linked to neoplasm.